FOLFOX plus cetuximab in first-line therapy of advanced colorectal cancer

Ann Transl Med. 2018 Dec;6(Suppl 2):S96. doi: 10.21037/atm.2018.11.22.

Authors

Roland Ehrenberg¹, Niels Halama¹

Affiliation

¹ National Center for Tumor Diseases, Department of Medical Oncology, University Hospital Heidelberg, Heidelberg, Germany.

No abstract available

Publication types

Editorial
Comment